Editas Medicine (EDIT)
(Real Time Quote from BATS)
$3.39 USD
+0.19 (5.94%)
Updated Oct 4, 2024 01:16 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/1/24 |
---|---|
Current Quarter | -0.75 |
EPS Last Quarter | -0.82 |
Last EPS Surprise | -18.84% |
ABR | 2.00 |
Earnings ESP
|
-18.04% |
---|---|
Current Year | -2.97 |
Next Year | -2.82 |
EPS (TTM) | -2.36 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.88M | 14.99M | 24.48M | 17.51M |
# of Estimates | 7 | 7 | 9 | 8 |
High Estimate | 27.50M | 50.00M | 52.16M | 28.00M |
Low Estimate | 0.51M | 0.51M | 1.60M | 2.67M |
Year ago Sales | 5.34M | 60.05M | 78.12M | 24.48M |
Year over Year Growth Est. | 47.57% | -75.03% | -68.67% | -28.48% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.75 | -0.65 | -2.97 | -2.82 |
# of Estimates | 10 | 8 | 12 | 10 |
Most Recent Consensus | -0.54 | -0.53 | -2.93 | -3.09 |
High Estimate | -0.44 | -0.17 | -2.39 | -2.12 |
Low Estimate | -0.89 | -0.89 | -3.39 | -3.74 |
Year ago EPS | -0.55 | -0.23 | -2.02 | -2.97 |
Year over Year Growth Est. | -36.36% | -182.61% | -47.03% | 5.02% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 2 | 0 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 8 | 6 | 12 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.75 | -0.65 | -2.97 | -2.82 |
7 Days Ago | -0.75 | -0.65 | -2.97 | -2.83 |
30 Days Ago | -0.75 | -0.65 | -2.97 | -2.83 |
60 Days Ago | -0.62 | -0.55 | -2.70 | -2.67 |
90 Days Ago | -0.62 | -0.55 | -2.70 | -2.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.89 | -0.65 | -3.39 | -3.03 |
Zacks Consensus Estimate | -0.75 | -0.65 | -2.97 | -2.82 |
Earnings ESP | -18.04% | 0.00% | -14.33% | -7.60% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.82 | -0.76 | -0.23 | -0.55 | NA |
Estimate | -0.69 | -0.63 | -0.52 | -0.64 | NA |
Difference | -0.13 | -0.13 | 0.29 | 0.09 | 0.03 |
Surprise | -18.84% | -20.63% | 55.77% | 14.06% | 7.59% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more